CohBar (NASDAQ:CWBR) is merging with privately held personalized cancer vaccine developer Morphogenesis and the combined company is expected to operate under the name TuHURA Biosciences Inc. Under the ...
TAMPA, Fla. (WFLA) – A Tampa company developing a skin cancer vaccine has recently appointed a new CEO who plans to take the company public within the next few months. Dr. James Bianco, an oncologist ...
TAMPA, Fla. (WFLA) – Tampa company Morphogenesis has received a “fast track” designation for its skin cancer vaccination from the United States Food and Drug Administration. Morphogenesis is a ...
(RTTNews) - CohBar, Inc. (CWBR) and Morphogenesis, Inc., a privately-held Phase 2/3 clinical-stage biotechnology company developing personalized cancer vaccines and tumor microenvironment modulators ...
Tissue engineering—creating a “seed” of tissue that could grow into a functional, life-saving organ—sounds like magic. But it could become technology, thanks in part to the work led by Lance Davidson, ...
The company is set to close a $21.6 million Series B round — but its CEO has even bigger plans in store. © 2025 American City Business Journals. All rights ...
A research team found that arginine metabolism has a vital role in regulating gametophore shoot formation in the moss Physcomitrium patens. Arginine metabolism boosts to make a plant body complex, ...
With the completion of the Anne T. and Robert M. Bass Biology Research Building at Stanford University, biology faculty and students who were once spread across campus were brought together under one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results